SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Novo Nordisk launches Wegovy pill in Germany

Novo Nordisk (NOVOB) has launched its Wegovy oral weight-loss pill in Germany, a spokesperson said, as investors focus on the treatment amid intensifying competition with Eli Lilly (LLY).

LLYNOVOB

Novo Nordisk OMXCOP:NOVO_B has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday, with investors keenly focused on the oral weight-loss treatment in light of intensifying competition with U.S. rival Eli Lilly NYSE:LLY.Novo was first to bring a highly effec…